Ladenburg Thalmann Financial Services’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $109K | Buy |
10,498
+5,703
| +119% | +$59.2K | ﹤0.01% | 2948 |
|
|
2019
Q3 | $19K | Buy |
4,795
+489
| +11% | +$1.94K | ﹤0.01% | 4085 |
|
|
2019
Q2 | $65K | Buy |
4,306
+1,160
| +37% | +$17.5K | ﹤0.01% | 3279 |
|
|
2019
Q1 | $77K | Buy |
3,146
+1,519
| +93% | +$37.2K | ﹤0.01% | 3084 |
|
|
2018
Q4 | $30K | Buy |
1,627
+1,013
| +165% | +$18.7K | ﹤0.01% | 3628 |
|
|
2018
Q3 | $18K | Sell |
614
-1,936
| -76% | -$56.8K | ﹤0.01% | 3985 |
|
|
2018
Q2 | $135K | Hold |
2,550
| – | – | ﹤0.01% | 2550 |
|
|
2018
Q1 | $135K | Buy |
2,550
+2,500
| +5,000% | +$132K | ﹤0.01% | 2550 |
|
|
2017
Q4 | $3K | Sell |
50
-114
| -70% | -$6.84K | ﹤0.01% | 4722 |
|
|
2017
Q3 | $13K | Sell |
164
-1,913
| -92% | -$152K | ﹤0.01% | 3953 |
|
|
2017
Q2 | $194K | Sell |
2,077
-73
| -3% | -$6.82K | ﹤0.01% | 2048 |
|
|
2017
Q1 | $137K | Sell |
2,150
-250
| -10% | -$15.9K | ﹤0.01% | 2191 |
|
|
2016
Q4 | $107K | Buy |
2,400
+400
| +20% | +$17.8K | ﹤0.01% | 2275 |
|
|
2016
Q3 | $72K | Buy |
+2,000
| New | +$72K | ﹤0.01% | 2498 |
|
|
2015
Q4 | – | Sell |
-13
| Closed | -$1K | – | 4825 |
|
|
2015
Q3 | $1K | Buy |
13
+3
| +30% | +$231 | ﹤0.01% | 4487 |
|
|
2015
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 4563 |
|
|
2015
Q1 | $1K | Sell |
10
-200
| -95% | -$20K | ﹤0.01% | 4481 |
|
|
2014
Q4 | $12K | Hold |
210
| – | – | ﹤0.01% | 3328 |
|
|
2014
Q3 | $10K | Sell |
210
-5,015
| -96% | -$239K | ﹤0.01% | 3113 |
|
|
2014
Q2 | $216K | Buy |
+5,225
| New | +$216K | 0.01% | 1154 |
|